Kristin Godang Selected Research

Aftercare (After-Treatment)

2/2024	Long-term Depot Specific Changes in Adipose Tissue after Treatment of Acromegaly.
12/2019	Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study.
1/2016	The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment.
2/2015	Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment.
1/2014	Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities.
6/2012	Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristin Godang Research Topics

Disease

8	Inflammation (Inflammations) 01/2022 - 07/2009
8	Insulin Resistance 01/2017 - 07/2009
7	Acromegaly 02/2024 - 12/2009
5	Primary Hyperparathyroidism 01/2023 - 04/2015
5	Gestational Weight Gain 01/2020 - 01/2008
4	Birth Weight (Birth Weights) 01/2020 - 01/2012
4	Overweight 01/2020 - 01/2008
4	Fatigue 01/2019 - 04/2014
3	Diabetes Mellitus 02/2024 - 09/2009
3	Obesity 01/2020 - 09/2009
3	Body Weight (Weight, Body) 09/2015 - 04/2014
3	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 04/2014 - 07/2007
3	Cushing Syndrome 01/2013 - 03/2002
3	Osteoporosis 06/2012 - 01/2008
3	Weight Gain 01/2012 - 01/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2011 - 07/2009
2	Lipodystrophy 01/2023 - 01/2023
2	Dementia (Dementias) 01/2022 - 01/2021
2	Congenital Abnormalities (Deformity) 01/2022 - 01/2012
2	Epstein-Barr Virus Infections 01/2019 - 01/2019
2	Hyperglycemia 01/2018 - 01/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018 - 07/2015
2	Glucose Intolerance 10/2015 - 09/2009
1	Dermatomyositis (Dermatopolymyositis) 01/2023
1	Synovitis 10/2022
1	Cognitive Dysfunction 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Hypercalcemia (Milk Alkali Syndrome) 01/2022
1	Delirium 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Intestinal Failure 10/2020
1	Prediabetic State (Prediabetes) 01/2020
1	Vitamin D Deficiency 11/2019
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Infections 01/2019
1	Polymorphic catecholergic ventricular tachycardia 01/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Pain (Aches) 01/2019
1	Lymphoma (Lymphomas) 04/2017

Drug/Important Bio-Agent (IBA)

17	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2008
7	Insulin (Novolin)FDA Link 01/2021 - 12/2009
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2009
6	Growth Hormone (Somatotropin)IBA 02/2024 - 09/2014
6	AdiponectinIBA 01/2023 - 09/2009
5	Insulin-Like Growth Factor I (IGF-1)IBA 02/2024 - 01/2010
5	AdipokinesIBA 01/2023 - 07/2009
5	LipidsIBA 01/2022 - 09/2014
4	CholesterolIBA 01/2021 - 07/2009
3	C-Reactive ProteinIBA 01/2022 - 04/2014
3	CytokinesIBA 01/2022 - 01/2010
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2009
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 07/2007
3	Vitamin D FDA LinkGeneric 10/2020 - 06/2012
3	LeptinIBA 01/2014 - 01/2010
3	OsteocalcinIBA 01/2010 - 01/2008
2	Insulin-Like PeptidesIBA 03/2024 - 10/2023
2	cortisol binding globulinIBA 01/2022 - 01/2012
2	Calcium Gluconate (CBG)IBA 01/2022 - 01/2012
2	CatecholaminesIBA 01/2022 - 01/2021
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 07/2007
2	oxidized low density lipoproteinIBA 01/2020 - 11/2016
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2013
2	LDL CholesterolIBA 11/2016 - 01/2014
2	GlucocorticoidsIBA 01/2016 - 06/2012
2	Clonidine (ST 155)FDA LinkGeneric 09/2015 - 04/2014
2	ThioredoxinsIBA 01/2014 - 01/2013
2	Phosphates (Orthophosphate)IBA 03/2013 - 06/2012
2	OsteoprotegerinIBA 12/2010 - 11/2004
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2010 - 12/2009
1	Anabolic AgentsIBA 10/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	KetonesIBA 10/2022
1	Ether (Diethyl Ether)IBA 10/2022
1	MetalsIBA 10/2022
1	Cortisone FDA Link 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Lipopolysaccharide ReceptorsIBA 01/2020
1	Cholesterol Ester Transfer ProteinsIBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	Illicit Drugs (Recreational Drugs)IBA 01/2019
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2019
1	Trinitrotoluene (TNT)IBA 01/2019
1	Troponin T (Troponin T1)IBA 01/2019
1	secretoneurinIBA 01/2019
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2019

Therapy/Procedure

6	Aftercare (After-Treatment) 02/2024 - 06/2012
5	Parathyroidectomy 01/2023 - 04/2015
4	Transplantation 01/2018 - 07/2008
2	Therapeutics 04/2017 - 01/2014
2	Kidney Transplantation 01/2017 - 07/2008
1	Sympathectomy (Sympathectomies) 01/2021
1	Home Parenteral Nutrition 10/2020
1	Resuscitation 01/2019
1	Induced Heart Arrest (Cardioplegia) 01/2019